Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Sage Therapeutics, Inc. Tender Offer
(NasdaqGM:SUPN),(NasdaqGM:SAGE), ROCKVILLE, Md., July 28, 2025 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc., a Delaware corporation (NASDAQ: SUPN) (“Supernus“, and the “Company”), today announced that the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR Act“), with respect to Supernus' proposed acquisition of Sage Therapeutics, Inc., a Delaware corporation (NASDAQ: SAGE) […]